AVDL   $13.615  0.18% Market Open

Avadel Pharmaceuticals PLC
Total Cash 71.38M
totalCashPerShare 0.741
EBITDA -97.23M
Total Debt 37.67M
quickRatio 2.369
currentRatio 2.819
Total Revenue 95.15M
debtToEquity 53.59
Revenue/Share 1.036
ROA -0.34445
ROE -0.99517
grossProfits
freeCashflow -78.18M
operatingCashflow -114.14M
earningsGrowth
revenueGrowth 26.743
grossMargins 0.94619006
ebitdaMargins -1.02188
operatingMargins -0.30698
profitMargins -1.1164
enterpriseValue 1.29B
forwardPE 20.147058
floatShares 83.23M
sharesOutstanding 96.27M
sharesShort 11.91M
sharesShortPriorMonth 11.37M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.79%
Short Ratio help_outline 11.87%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 0.731
Price To Book help_outline 18.74
earningsQuarterlyGrowth
netIncomeToCommon -106.22M
trailingEps -1.09%
forwardEps 0.68%
enterpriseToEbitda -13.22
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.05 3Q 2024
institutionsCount 207
lastUpdated Sept. 16, 2024, 3:11 p.m.